Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

BE study design issue [Design Issues]

posted by Dr_Dan – Germany, 2019-12-18 16:04 (2384 d 21:33 ago) – Posting: # 20992
Views: 6,871

Hi John
if the recommended dosage regimen of the IR as per product monograph IR is to be given every 4 hrs then this means that higher doses have either a safety issue or the dose/effect relationship is in disfavor of higher doses. In this case AUC alone does not matter. Consequently, a regulatory body will reject the study
Hope this helps
KR
Dr_Dan

—
Kind regards and have a nice day
Dr_Dan

Complete thread:

BE study design issue jag009 2019-12-13 23:26
- 1×2 ≠ 2×1 Helmut 2019-12-14 00:42
  - 1×2 ≠ 2×1 jag009 2019-12-15 19:39
    - 1×2 ≠ 2×1 ElMaestro 2019-12-15 22:02
      - x ◦ y = y ◦ x? Helmut 2019-12-16 11:00
- BE study design issueDr_Dan 2019-12-18 15:04
  - ER vs. IR Helmut 2019-12-18 15:33
    - ER vs. IR Dr_Dan 2019-12-19 09:01

Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
280 visitors (1 registered, 279 guests [including 21 identified bots]).
Forum time: 14:38 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas. Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz